NEW YORK, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nanorobotics space, has today obtained a detailed chemical profile and analysis of effluent discharged from a major United States ("U.S.") based nuclear power plant (pressurized water reactor). This is an important first step in developing a customized bacterial robot for the nuclear energy production industry. The effluent discharge pertaining to nuclear power plants is defined as liquid waste and pollutants discharged into the surface of a surrounding body of water (i.e. rivers, lakes, seas, or oceans). In the process of generating electricity, nuclear power plants utilize hundreds of thousands of gallons of water per minute to cool the plant systems. The internal Liquid Waste Disposal System ("LWDS") of a power plant is constructed to detect, remove, collect, store, process and transfer all liquid waste for controlled release into the surrounding body of water within the limits of Federal Regulation 10CFR20 during normal operations. The treatment and processing of effluent discharge is both a major operating cost for the nuclear plants and a source of friction within environmental agencies and activists.
On October 29, 2013 Tauriga announced a comprehensive Strategic Alliance with Cincinnati, Ohio-based Bacterial Robotics LLC and its wastewater-to-value subsidiary, Pilus Energy. The Agreement stipulates the formation of a Joint Venture Partnership ("JVP") for the development and commercialization of a nuclear power industry specific Bacterial Robot, or BactoBot(TM). The Company plans to incorporate the chemical profile of the effluent into its whitepaper on the feasibility of engineering a BactoBot prototype ("NuclearBot") to potentially treat and remediate such wastewater. The next step will be to work with Novel Device Lab ("NDL") at University of Cincinnati and its director, Dr. Jason Heikenfeld ("Dr. Heikenfeld"), to develop a strategy for rapid-prototyping. On October 31, 2013 Tauriga announced that Dr. Heikenfeld was appointed as the 3rd member of the Company's scientific advisory board.
In addition, the Company is actively compiling information to accurately estimate the potential market size of the addressable market defined as cleaning and remediation of nuclear power plant effluent. Compilation of such estimates will include all cost variables, such as: storage costs, filtration systems, monitoring and detection technologies, discharge of water, dilution of contaminated water, and municipal fines and penalties. The Company is also working diligently to identify the practical application(s) of its NuclearBot, should the Company be successful in developing a working prototype. Once the company is comfortable with its estimate of the addressable market size and the corresponding technology application(s), shareholders will be notified through a press release.
Tauriga's CEO Seth M. Shaw commented, "The Company has established a roadmap for rapidly developing the BactoBot technology based on initially identifying the puzzle to solve, then building a prototype, followed by practical application of such technology. Obtaining the chemical profile of nuclear power plant effluent enables the Company to move forward with development work and now our laboratory partners can incorporate an effective game plan."
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at www.tauriga.com.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.